Profile of semaglutide in the management of type 2 diabetes: design, development, and place in therapy

Overview of attention for article published in Drug Design, Development and Therapy, February 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

video: 1 YouTube creator

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 85 Mendeley

Summary X YouTube Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Biology and Clinical Use of Glucagon-Like Peptide-1 Receptor Agonists in Vascular Protection

Article in Canadian Journal of Cardiology (July 2023)

GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms

Article in Journal of Diabetes and its Complications (June 2023)

Therapeutic inertia related to the injectable glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care

Article in Diabetes Obesity and Metabolism (February 2023)